Savant Capital’s Bausch Health BHC Stock Holding History

Savant Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-38,160	Closed	-$206K	–	1852
2026 Q1	$206K	Buy	38,160 +156	+0.4%	+$934	﹤0.01%	1393
2025 Q4	$264K	Buy	+38,004	New	+$250K	﹤0.01%	1135

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Savant Capital's BHC Position: Q2 2026 in Review

Savant Capital sold out of Bausch Health (BHC) in Q2 2026, closing a stake of 38,160 shares — an estimated $206K sold.

Savant Capital first reported a position in BHC in Q4 2025 and held it in 2 quarters. The position peaked at $264K in Q4 2025. 221 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

Savant Capital reported no remaining Bausch Health position as of Q2 2026 after selling out during the quarter.
Savant Capital sold 38,160 Bausch Health shares in Q2 2026, an estimated $206K.
Savant Capital first reported a position in Bausch Health in Q4 2025 and held it in 2 quarters.
Savant Capital's Bausch Health position peaked at $264K in Q4 2025.
221 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.